SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate actions, if and when needed, in order to evaluate and update all information regarding the benefit-risk of our products.

The SIFI Group Vigilance system includes:
Vigilance of medical devices
Vigilance of surgical devices

Pharmacovigilance allows:
  • learning more about drugs, properly informing the doctors who prescribe them and protecting patients who take them;
  • to ensure that the drugs available on the market may have a favourable benefit-risk for the population.

What is an adverse reaction?

A response to a medicinal product which is noxious and unintended, including:
• uses within the terms of the marketing authorisation.
• uses outside the terms of the marketing authorisation: off-label use, overdose, misuse, abuse and medication errors, as well as associated with exposure for professional reasons.

Whenever an adverse reaction or side effect occurs during therapy, it should be promptly reported to a doctor or pharmacist.

How to report an adverse reaction?

For consumers
Every citizen can report a suspected adverse reaction through an appropriate "Template form for citizens reporting side effects", which can be downloaded from the website of the Agenzia Italiana del Farmaco - Italian Medicines Agency (AIFA) at the following address:

For health professionals
Health professionals can report a suspected adverse reaction through the "Reporting of suspected adverse reaction form" which can be downloaded from the website of the Agenzia Italiana del Farmaco - Italian Medicines Agency (AIFA) to this address:

Find out more

The filled out form should be sent to the Head of Pharmacovigilance of local health centre you belong to.
The complete list of Head of Pharmacovigilance of the different health facilities, divided by region, is available at the following address:

to find out more ...

Spontaneous reports of adverse reactions to drugs (ADRs) that occur in Italy are collected by the National Network of Pharmacovigilance - Rete Nazionale di Farmacovigilanza - (RNF), promoted and managed by AIFA (Italian Medicines Agency).

In addition, Italy with all other member states is part of a European Pharmacovigilance system and operates in accordance with European legislation established by the European Medicines Agency (EMA).


AIFA, with its website, provides constant updates regarding Pharmacovigilance:
SIFI S.p.A. Pharmacovigiliance Service
Tel.: +39 095 7922204 -  +39 095 7922356
Fax: +39 095 789 34 51


Vigilance of medical devices

The DispoVigilance for medical devices is a System for the collection of alerts that occur with the use of a medical device aimed at improving the health and safety of users, reducing the probability of occurrence of the same type of Incident.

What is a Medical device?

An instrument, a device, a system, a substance or other, used alone or in combination, including the software necessary for the proper functioning, intended by the manufacturer to be used on people for the purpose of:
•    diagnosis, prevention, monitoring, treatment or alleviation of a disease,
•    diagnosis, monitoring, treatment, alleviation or compensation of an injury or handicap,
•    investigation, replacement or modification of the anatomy or of a physiological process
•    intervention on conception,
provided they do not perform its principal action in or on the human body, to which it is intended, by pharmacological immunological means, nor through metabolic process, but whose function may be assisted by such means.


What is an Incident?

a) any malfunction or change in the characteristics and performance of a medical device, as well as any inadequacy in the labelling or the instructions of use that may be or have been the cause of death or serious deterioration of the health conditions of a patient or a user;
b) any technical or medical reason in relation to the characteristics or performances of a medical device that, for the reasons referred to in point (a), leads to the systematic recall of devices of the same type by the manufacturer.


How to report an incident?

The public and private health care providers can report an incident occurring with a medical device through the "Incident report by healthcare professionals by the Ministry of Health" available at the following address:
Health care professionals are invited to submit the same informing SIFI SpA as well through the form available at the following address:

to find out more ...

The Ministry of Health has the duty to assess and record the data related to incidents with medical devices. With its website, it also offers to the Citizen, constant updates regarding DispoVigilance for medical devices.
All Member States will then add the collected data to the centralised european database - European Database for Medical Devices (EUDAMED) - in order to improve knowledge on the use of these products.


SIFI S.p.A. monitoring device Contact Service
Tel.: +39 095 79 22 204 - +39 095 79 22 252 - +39 095 79 22 371.
Fax: +39 095 789 34 51

Vigilance of Surgical devices

In accordance with the provisions of the Medical Device Vigilance Guideline (MEDDEV 2.12.1), SIFI S.p.A. actively runs a post-marketing monitoring system on its products. This activity is useful to verify customer's perceptions on the quality and performance characteristics of devices and ensures, through continuous monitoring, product safety.

SIFI S.p.A. monitoring device Contact Service
Tel.: +39 095 79 22 204 - +39 095 79 22 252 - +39 095 79 22 371.
Fax: +39 095 789 34 51

Subject of the inquiry*
Description of the inquiry
Informativa sulla privacy

I confirm that I have read the privacy statement and on the basis of that:

Confirmation Code* :



On our Social Channels

From our News Center

SIFI, the main Italian ophthalmic pharmaceutical company, is actively involved in the fight against COVID-19, and is alongside physicians, nurses and health personnel, to help face together the...


23 October

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian...
Follow Us!